{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:02:57Z","timestamp":1787500977661,"version":"build-2736575974"},"reference-count":8,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"DOI":"10.1210\/clinem\/dgaf503","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:34:26Z","timestamp":1757417666000},"page":"e1914-e1915","source":"Crossref","is-referenced-by-count":2,"title":["Low-dose Methimazole in the Long-term Management of Graves' Disease: Small Doses, Big Benefits"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4173-7258","authenticated-orcid":false,"given":"Danilo","family":"Villagelin","sequence":"first","affiliation":[{"name":"School of Life Sciences, Faculty of Medicine, Pontifical Catholic University of Campinas , Campinas, SP 13034-685 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-6400","authenticated-orcid":false,"given":"David S","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"11","key":"2026061619573868800_dgaf503-B1","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","article-title":"A 2023 International survey of clinical practice patterns in the management of Graves disease: a decade of change","volume":"109","author":"Villagelin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026061619573868800_dgaf503-B2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"2026061619573868800_dgaf503-B3","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.beem.2022.101631","article-title":"Long-term thionamide antithyroid treatment of Graves' disease","volume":"37","author":"Azizi","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2026061619573868800_dgaf503-B4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-57-3-563","article-title":"Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism","volume":"57","author":"Romaldini","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"(2)","key":"2026061619573868800_dgaf503-B5","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1210\/clinem\/dgaf433","article-title":"Impact of minimal dose strategy before antithyroid drug discontinuation on relapse risk in Graves' disease","volume":"111","author":"Miyamura","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026061619573868800_dgaf503-B6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3803\/EnM.2016.31.2.300","article-title":"Usefulness of measuring thyroid stimulating antibody at the time of antithyroid drug withdrawal for predicting relapse of Graves disease","volume":"31","author":"Kwon","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"2026061619573868800_dgaf503-B7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"2026061619573868800_dgaf503-B8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves' disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf503\/64237422\/dgaf503.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1914\/64237422\/dgaf503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1914\/64237422\/dgaf503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:57:46Z","timestamp":1781654266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/7\/e1914\/8250747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":8,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf503","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2025,9,10]]}}}